Ensysce Biosciences (ENSC) Stock Chart & Stock Price History $2.14 +0.07 (+3.38%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ensysce Biosciences Stock Price Performance The Ensysce Biosciences (ENSC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 73.38%, with a year-to-date return of -73.71%. In the past month, the stock has decreased 2.28%, reflecting recent market activity. As of the latest close, Ensysce Biosciences traded at $2.07 with a market cap of $4.91 million and volume of 129,502 shares. Receive ENSC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.08%1 Month Performance-2.28%3 Month Performance-53.07%Year-To-Date Performance-73.71%1 Year Performance-73.38% ENSC Stock Chart for Thursday, June, 12, 2025 ENSC Chart by TradingView Ensysce Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$2.07$2.14+3.38%$2.17$2.0452,706 shs$5.07 million06/11/2025$2.04$2.07+1.47%$2.15$1.99129,502 shs$4.91 million06/10/2025$2.33$2.04-12.45%$2.32$2.02239,734 shs$4.84 million06/09/2025$2.38$2.33-2.10%$2.47$2.2679,264 shs$5.52 million06/06/2025$2.34$2.38+1.71%$2.52$2.2977,921 shs$5.64 million06/05/2025$2.38$2.34-1.68%$2.47$2.26203,818 shs$5.55 million06/04/2025$2.30$2.38+3.48%$2.57$2.123.29 million shs$5.64 million06/03/2025$2.22$2.30+3.60%$2.33$2.2039,121 shs$5.45 million06/02/2025$2.19$2.22+1.37%$2.29$2.1824,790 shs$5.26 million05/30/2025$2.19$2.19$2.28$2.1633,033 shs$5.19 million Get the Latest News and Ratings for ENSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$2.26$2.19-3.10%$2.27$2.1339,138 shs$5.19 million05/28/2025$2.38$2.26-5.04%$2.37$2.2449,552 shs$5.36 million05/27/2025$2.20$2.38+8.18%$2.40$2.1950,752 shs$5.64 million05/26/2025$2.20$2.20$2.22$2.1131,449 shs$5.22 million05/23/2025$2.17$2.20+1.38%$2.22$2.1131,449 shs$5.22 million05/22/2025$2.23$2.17-2.69%$2.24$2.0958,269 shs$5.15 million05/21/2025$2.42$2.23-7.85%$2.41$2.10158,796 shs$5.29 million05/20/2025$2.55$2.42-5.10%$2.63$2.3370,822 shs$5.74 million05/19/2025$2.34$2.55+8.97%$2.60$2.26215,512 shs$6.05 million05/16/2025$2.14$2.34+9.35%$2.40$2.11203,471 shs$5.55 million05/15/2025$2.31$2.14-7.36%$2.38$2.13234,146 shs$5.07 million05/14/2025$2.07$2.31+11.59%$2.40$2.103.38 million shs$5.48 million05/13/2025$2.19$2.07-5.48%$2.23$1.99531,008 shs$4.91 million05/12/2025$2.17$2.19+0.92%$2.34$2.07135,827 shs$5.19 million Related Companies SXTC Stock Price Chart OVID Stock Price Chart NAII Stock Price Chart SLGL Stock Price Chart BIVI Stock Price Chart CGTX Stock Price Chart CMMB Stock Price Chart ASBP Stock Price Chart LGVN Stock Price Chart ELEV Stock Price Chart Receive ENSC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENSC) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersElon’s final win for Social Security?Elon's Successor? Elon Musk and President Trump's new feud is all over the news... but before he left Washi...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
